Title : No Extra Liver Cancer Risk with Interferon-Free HCV Regimens
link : No Extra Liver Cancer Risk with Interferon-Free HCV Regimens
No Extra Liver Cancer Risk with Interferon-Free HCV Regimens
No Extra Liver Cancer Risk with Interferon-Free HCV Regimens
by Diana Swift, March 25, 2018
Earlier suggestions not supported in retrospective study of 857 patients
Successful treatment of cirrhotic patients with hepatitis C virus (HCV) with direct-acting interferon (IFN)-free antiviral therapy did not increase the risk of incident hepatocellular carcinoma (HCC), researchers said, nor was it associated with increased nodule size or number in those diagnosed with HCC.
According to a Scottish study published in the Journal of Hepatology, the elevated risk suggested by previous research was attenuated after accounting for differing characteristics between patients given regimens with or without interferon.
Continue reading: https://www.medpagetoday.com/gastroenterology/hepatitis/71969
Resource Link
Liver Cancer After Treatment For Hepatitis CThis page offers an index of links to current data investigating the possible risk of developing liver cancer (hepatocellular carcinoma, or HCC) during and after direct-acting antiviral therapy in patients with hepatitis C.
Thus Article No Extra Liver Cancer Risk with Interferon-Free HCV Regimens
That's an article No Extra Liver Cancer Risk with Interferon-Free HCV Regimens This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article No Extra Liver Cancer Risk with Interferon-Free HCV Regimens with the link address https://theleknews.blogspot.com/2018/03/no-extra-liver-cancer-risk-with.html
0 Response to "No Extra Liver Cancer Risk with Interferon-Free HCV Regimens"
Post a Comment